Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice. [electronic resource]
- Scientific reports 05 2016
- 26742 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
2045-2322
10.1038/srep26742 doi
Amides--pharmacology Animals Dogs Drug Therapy, Combination Female Influenza A Virus, H5N1 Subtype Madin Darby Canine Kidney Cells Mice Mice, Inbred BALB C Orthomyxoviridae Infections--drug therapy Oseltamivir--pharmacology Pyrazines--pharmacology